The global live cell encapsulation market is expected to record a CAGR of 3.97% from 2023 to 2033. In 2023, the market size is projected to reach a valuation of US$ 219.06 million. By 2033, the valuation is likely to be worth US$ 323.33 million.
Target-specific therapies and increased awareness of their potential benefits are the key reason for market growth. As a result, there has been a surge in investments from both public and private partnerships to support this technology.
Following are the Market’s Growth Drivers:
Increasing Demand for Regenerative Medicine:
Regenerative medicine is an emerging field that aims to restore the normal function of damaged or diseased tissues and organs. Live cell encapsulation plays a crucial role in regenerative medicine. As it enables the delivery of live cells to targeted sites, where they can regenerate damaged tissues. The increasing growth of the regenerative medicine market is driving the demand for live cell encapsulation technology.
Growing Investments in Research and Development:
Governments and private organizations are investing heavily in research and development activities. The aim behind the investment is to improve the efficacy and safety of live cell encapsulation. These investments are expected to fuel the growth of the market in the coming years.
Technological Advancements:
The development of new technologies has enabled the production of more efficient and effective live cell encapsulation systems. For instance, the use of microfluidics and 3D printing has improved the precision and scalability of live cell encapsulation, making it more commercially viable.
Rising Prevalence of Chronic Diseases:
Chronic diseases such as diabetes, Parkinson's disease, and cancer are on the rise globally. Live cell encapsulation has emerged as a promising therapy for these conditions. As it can deliver live cells to targeted sites and promote tissue regeneration. The increasing prevalence of chronic diseases is expected to drive the demand for live cell encapsulation in the coming years.
Increasing Awareness about the Benefits of Live Cell Encapsulation:
As more research is conducted on live cell therapy and its potential applications, healthcare providers and patients are increasingly aware of its benefits.
| Attributes | Value |
|---|---|
| Live Cell Encapsulation Value (2022) | US$ 210.7 million |
| Live Cell Encapsulation Market Expected Value (2023) | US$ 219.06 million |
| Live Cell Encapsulation Market Forecast Value (2033) | US$ 323.33 million |
| Live Cell Encapsulation Market Expected CAGR (2023 to 2033) | 3.97% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Sernova Corp. Acquired Cell Pouch System:
In 2020, Sernova Corp., a clinical-stage company acquired the Cell Pouch System from a private firm, Sanwa Kagaku Kenkyusho Co. Ltd. This acquisition has enabled Sernova Corp. to expand its regenerative medicine product pipeline by integrating the Cell Pouch System, which is a live-cell encapsulation device.
Living Cell Technologies Limited Merged with Viacyte:
In 2019, Living Cell Technologies Limited, a biotechnology company that develops encapsulated cell therapies, merged with Viacyte. The company is focused on developing regenerative therapies for diabetes. This merger enabled the combined entity to expand its product portfolio and accelerate the development of encapsulated cell therapies for diabetes.
Evotec SE acquired Just Biotherapeutics:
In 2019, Evotec SE, a German drug discovery and development company, acquired Just Biotherapeutics. A company specializing in the development of engineered proteins for therapeutic use. This acquisition enabled Evotec SE to integrate Just Biotherapeutics' technology. This includes its live-cell encapsulation platform in its product portfolio and enhances its capabilities in the field of regenerative medicine.
These mergers and acquisitions have allowed companies to expand their product portfolios. Moreover, it leverages complementary technologies and strengthens its position in the live cell encapsulation market.
Live Cell Encapsulation Market:
| Differentiating Aspects | Live Cell Encapsulation Market |
|---|---|
| Anticipated CAGR (2023 to 2033) | 3.97% |
| Market Valuation (2023) | US$ 219.06 million |
| Growth Factors | The market is driven by an increase in demand for regenerative medicine. |
| Future Opportunities | Governments and financial institutions are making significant investments in research and development activities. |
| Market Trends | In the upcoming years, the need for live-cell encapsulation is anticipated to increase due to the rising frequency of chronic diseases. |
Respiratory Pathogen Testing Kits Market:
| Differentiating Aspects | Respiratory Pathogen Testing Kits Market |
|---|---|
| Anticipated CAGR (2023 to 2033) | 5.7% |
| Market Valuation (2023) | US$ 4,083.1 million |
| Growth Factors | Rising chronic illness prevalence and increasing pathogen testing and preventative healthcare awareness. |
| Future Opportunities | The market for respiratory pathogen testing kits is driven by a significant increase in respiratory illness incidences. |
| Market Trends | Future market demand is likely to be profitable since developing and emerging economies have access to improved healthcare facilities. |
Microneedle Drug Delivery Systems Market:
| Differentiating Aspects | Microneedle Drug Delivery Systems Market |
|---|---|
| Anticipated CAGR (2023 to 2033) | 6.6% |
| Market Valuation (2023) | US$ 768.9 million |
| Growth Factors | The rising population of obese people. |
| Future Opportunities | The increased focus on improving the state of healthcare facilities and the infrastructure for healthcare as a whole. |
| Market Trends | Increased public-private partnerships and strategic partnerships. |
Principal Consultant
Overall, these factors may restrain the growth of the live cell encapsulation market. On that account, companies operating in this market might need to address these challenges to succeed.
The microencapsulation segment accounted for a significant market share of 64.17% in 2023. This technique involves the formulation of a bioactive substance into a particle size of 1-1000 μm in diameter.
Microencapsulation has several applications in therapeutic delivery for the treatment of various diseases, such as cancer, tuberculosis, diabetes, rheumatoid arthritis, and respiratory tract infection. For example, microencapsulated islets of Langerhans can be implanted in the body for long-term treatment of diabetes or other diseases that require organ transplantation.
The growth of the microencapsulation segment is primarily driven by its therapeutic applications. On the other hand, the nanoencapsulation segment is projected to expand at a significant CAGR during the forecast period.
Nanoencapsulation technology is widely used in the development of drug delivery systems. The delivery of encapsulated diagnostic/therapeutic agents depends on the size of the nanoparticle. Therefore, the use of nanoencapsulation technology is considered crucial in designing effective drug delivery systems, which is expected to drive segment growth.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
In 2023, the drug delivery segment is expected to account for a significant revenue share of 44.60%.
The use of live cell encapsulation technology in the manufacturing of capsules, tablets, and parenteral dosage forms is crucial for effective drug delivery. Controlled drug delivery has enormous potential in diseases with progressive deterioration.
Live cell encapsulation provides advantages such as enhanced therapeutic effects, reduced drug dosage, lowered cytotoxicity, improved patient convenience, and compliance, which are driving the growth of this segment. Besides, the regenerative medicine segment is anticipated to record a rapid CAGR over the forecast period.
Regenerative medicine is an emerging field that uses stem cells as a cell-based therapy to regenerate or restore damaged tissues or organs. Stem cell encapsulation can provide various advantages in regenerative medicine, including improved cell viability, proliferation, and differentiation.
To support regenerative medicine, many industry players are implementing various strategies. For example, Invetech plans to deliver three GMP encapsulation devices in 2023 to support TreeFrog's in-house and partnered cell therapy programs in regenerative medicine and immuno-oncology. These types of initiatives are expected to drive the growth of the regenerative medicine segment during the forecast period.
North America is expected to dominate the live cell encapsulation market, holding a market share of 36.72% in 2023. The region's significant market share can be attributed to several factors including:
North America's focus on research in the area of drug discovery is also contributing to the growth of the industry. The region is home to many innovators and key operating players, resulting in higher penetration of live cell encapsulation products and therapies. For example, ViaCyte, Inc. recently announced the initiation of phase 2 clinical study of encapsulated cell therapy. The clinical study is initiated to treat type 1 diabetes patients, highlighting the region's focus on innovation and advancing the field.
A Rise in Chronic Diseases:
The high incidence of chronic diseases, such as diabetes, cancer, and cardiovascular diseases in North America. This is creating a strong demand for regenerative medicine and cell-based therapies, including live cell encapsulation. This trend is expected to fuel significant growth in the live cell encapsulation market in the region. As healthcare providers seek innovative solutions to address the increasing burden of chronic diseases.
Favorable Regulatory Environment:
North America has a favorable regulatory environment for regenerative medicine and cell-based therapies. This has encouraged the development and commercialization of live cell encapsulation products and therapies. The streamlined regulatory pathway is expected to drive the growth of the market in North America.
Increasing Awareness about Personalized Medicine:
The concept of personalized medicine is gaining traction in Europe, which is driving the demand for cell-based therapies. Live cell encapsulation allows for the customization of therapy based on the patient’s individual needs.
Growing Demand for Organ Transplantation:
The shortage of organs for transplantation is a crucial challenge in Europe. Live cell encapsulation offers a potential solution to this problem, as it enables the production of artificial organs and tissues.
Asia Pacific: The Live Cell Encapsulation Market
The live cell encapsulation market in Asia Pacific is expected to record a significant CAGR over the forecast period. This growth can be attributed to the advancements in the biotechnology and pharmaceutical industries in emerging economies, particularly in India and China. The continuous government support for developing the pharmaceutical sector in these countries is also contributing to the region's profitable expansion.
The aging population in the Asia Pacific region is increasing rapidly, which is driving the demand for healthcare services. Live cell encapsulation is an effective approach for the treatment of age-related diseases such as Parkinson’s and Alzheimer’s disease. This in turn is driving the demand for this technology in the region.
Governments in the Asia Pacific region are providing support for the development of the biotechnology sector, which includes live cell encapsulation. This is creating opportunities for companies in the region to develop and commercialize new products and technologies in this field.
The global live cell encapsulation market is witnessing rapid growth, thanks to the strategic initiatives being implemented by key players in the industry. BIO INX, a manufacturing company recently launched innovative and biocompatible high-resolution bioink HYDROBIO INX for live cell encapsulation. Notable companies operating in this market include:
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | US$ million for Value |
| Key Regions Covered |
|
| Key Countries Covered |
|
| Key Market Segments Covered |
|
| Key Companies Profiled |
|
| Pricing | Available upon Request |
Drug delivery holds high revenue potential.
The United States, Canada, and China is estimated to dominate the global market.
The market is forecast to register a CAGR of 3.97% through 2033.
During 2018 to 2022, the market registered a CAGR of 3.97%.
Rising frequent chronic diseases are the current market trends.
1. Executive Summary | Live Cell Encapsulation Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Polymer Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Polymer Type, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Polymer Type, 2023 to 2033 5.3.1. Natural Polymers 5.3.2. Synthetic Polymers 5.4. Y-o-Y Growth Trend Analysis By Polymer Type, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Polymer Type, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Method 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Method, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Method, 2023 to 2033 6.3.1. Microencapsulation 6.3.2. Macroencapsulation 6.3.3. Nanoencapsulation 6.4. Y-o-Y Growth Trend Analysis By Method, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Method, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By Application, 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2023 to 2033 7.3.1. Drug Delivery 7.3.2. Regenerative Medicine 7.3.3. Cell Transplantation 7.3.4. Other Applications 7.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022 7.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022 8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. South Asia 8.3.5. East Asia 8.3.6. Oceania 8.3.7. MEA 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. The USA 9.2.1.2. Canada 9.2.2. By Polymer Type 9.2.3. By Method 9.2.4. By Application 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Polymer Type 9.3.3. By Method 9.3.4. By Application 9.4. Key Takeaways 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Polymer Type 10.2.3. By Method 10.2.4. By Application 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Polymer Type 10.3.3. By Method 10.3.4. By Application 10.4. Key Takeaways 11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. United Kingdom 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Europe 11.2.2. By Polymer Type 11.2.3. By Method 11.2.4. By Application 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Polymer Type 11.3.3. By Method 11.3.4. By Application 11.4. Key Takeaways 12. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. India 12.2.1.2. Malaysia 12.2.1.3. Singapore 12.2.1.4. Thailand 12.2.1.5. Rest of South Asia 12.2.2. By Polymer Type 12.2.3. By Method 12.2.4. By Application 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Polymer Type 12.3.3. By Method 12.3.4. By Application 12.4. Key Takeaways 13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. China 13.2.1.2. Japan 13.2.1.3. South Korea 13.2.2. By Polymer Type 13.2.3. By Method 13.2.4. By Application 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Polymer Type 13.3.3. By Method 13.3.4. By Application 13.4. Key Takeaways 14. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. Australia 14.2.1.2. New Zealand 14.2.2. By Polymer Type 14.2.3. By Method 14.2.4. By Application 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Polymer Type 14.3.3. By Method 14.3.4. By Application 14.4. Key Takeaways 15. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. South Africa 15.2.1.3. Israel 15.2.1.4. Rest of MEA 15.2.2. By Polymer Type 15.2.3. By Method 15.2.4. By Application 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Polymer Type 15.3.3. By Method 15.3.4. By Application 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. USA 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2022 16.1.2.1. By Polymer Type 16.1.2.2. By Method 16.1.2.3. By Application 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2022 16.2.2.1. By Polymer Type 16.2.2.2. By Method 16.2.2.3. By Application 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2022 16.3.2.1. By Polymer Type 16.3.2.2. By Method 16.3.2.3. By Application 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2022 16.4.2.1. By Polymer Type 16.4.2.2. By Method 16.4.2.3. By Application 16.5. Germany 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2022 16.5.2.1. By Polymer Type 16.5.2.2. By Method 16.5.2.3. By Application 16.6. United Kingdom 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2022 16.6.2.1. By Polymer Type 16.6.2.2. By Method 16.6.2.3. By Application 16.7. France 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2022 16.7.2.1. By Polymer Type 16.7.2.2. By Method 16.7.2.3. By Application 16.8. Spain 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2022 16.8.2.1. By Polymer Type 16.8.2.2. By Method 16.8.2.3. By Application 16.9. Italy 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2022 16.9.2.1. By Polymer Type 16.9.2.2. By Method 16.9.2.3. By Application 16.10. India 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2022 16.10.2.1. By Polymer Type 16.10.2.2. By Method 16.10.2.3. By Application 16.11. Malaysia 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2022 16.11.2.1. By Polymer Type 16.11.2.2. By Method 16.11.2.3. By Application 16.12. Singapore 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2022 16.12.2.1. By Polymer Type 16.12.2.2. By Method 16.12.2.3. By Application 16.13. Thailand 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2022 16.13.2.1. By Polymer Type 16.13.2.2. By Method 16.13.2.3. By Application 16.14. China 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2022 16.14.2.1. By Polymer Type 16.14.2.2. By Method 16.14.2.3. By Application 16.15. Japan 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2022 16.15.2.1. By Polymer Type 16.15.2.2. By Method 16.15.2.3. By Application 16.16. South Korea 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2022 16.16.2.1. By Polymer Type 16.16.2.2. By Method 16.16.2.3. By Application 16.17. Australia 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2022 16.17.2.1. By Polymer Type 16.17.2.2. By Method 16.17.2.3. By Application 16.18. New Zealand 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2022 16.18.2.1. By Polymer Type 16.18.2.2. By Method 16.18.2.3. By Application 16.19. GCC Countries 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2022 16.19.2.1. By Polymer Type 16.19.2.2. By Method 16.19.2.3. By Application 16.20. South Africa 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2022 16.20.2.1. By Polymer Type 16.20.2.2. By Method 16.20.2.3. By Application 16.21. Israel 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2022 16.21.2.1. By Polymer Type 16.21.2.2. By Method 16.21.2.3. By Application 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Polymer Type 17.3.3. By Method 17.3.4. By Application 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. AUSTRIANOVA 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.2. Merck KGaA 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.3. Sphere Fluidics Ltd. 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.4. ViaCyte, Inc. 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.5. Blacktrace Holdings Ltd. 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.6. BIO INX 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.7. Living Cell Technologies Ltd. 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.8. Sigilon Therapeutics, Inc. 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.9. Isogen 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.10. Diatranz Otsuka Ltd. 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports
Live Cell Encapsulation Market
